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Abstract
Background Work in humans has shown that impulsivity can be advantageous in certain settings. However, evidence for so-
called functional impulsivity is lacking in experimental animals.
Aims This study investigated the contexts in which high impulsive (HI) rats show an advantage in performance compared with
mid- (MI) and low impulsive (LI) rats. We also assessed the effects of dopaminergic and noradrenergic agents to investigate
underlying neurotransmitter mechanisms.
Methods We tested rats on a variable inter-trial interval (ITI) version of the 5-choice serial reaction time task (5CSRTT). Rats
received systemic injections of methylphenidate (MPH, 1 mg/kg and 3 mg/kg), atomoxetine (ATO, 0.3 mg/kg and 1 mg/kg),
amphetamine (AMPH, 0.2 mg/kg), the alpha-2a adrenoceptor antagonist atipamezole (ATI, 0.3 mg/kg) and the alpha-1
adrenoceptor agonist phenylephrine (PHEN, 1 mg/kg) prior to behavioural testing.
Results Unlike LI rats, HI rats exhibited superior performance, earning more reinforcers, on short ITI trials, when the task
required rapid responding. MPH, AMPH and ATI improved performance on short ITI trials and increased impulsivity in long
ITI trials, recapitulating the behavioural profile of HI. In contrast, ATO and PHEN impaired performance on short ITI trials and
decreased impulsivity, thus mimicking the behavioural profile of LI rats. The effects of ATO were greater onMI rats and LI rats.
Conclusions These findings indicate that impulsivity can be advantageous when rapid focusing and actions are required, an effect
that may depend on increased dopamine neurotransmission. Conversely, activation of the noradrenergic system, with ATO and
PHEN, led to a general inhibition of responding.
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Introduction
Impulsivity is a multifactorial construct more generally under-
stood as the tendency to act prematurely without foresight
(Dalley et al. 2011; Evenden 1999; Whiteside and Lynam
2001; Winstanley et al. 2006). It is often regarded as a mal-
adaptive trait and indeed is widely associated with various
psychiatric disorders, including drug addiction (de Wit 2009;
Jentsch and Taylor 1999; Kollins et al. 2005) and attention-
deficit hyperactivity disorder (ADHD, Solanto 2002).
However, impulsivity need not be an exclusively dysfunction-
al trait and may even be advantageous in certain contexts
(Dickman 1985; Dickman 1990; Smillie and Jackson 2006;
Cools et al. 2005).
Dickman (1990, 2000) advanced the concept of functional
impulsivity, that is ‘the tendency to engage in rapid, error-
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prone information processing when such a strategy is (..) op-
timal’, (p.101, Dickman 1990). Based on research in human
subjects, Dickman concluded that when the experimental task
is very simple, the rapid responding typical of ‘high impul-
sives’ does not lead to a higher rate of errors (Dickman 1985).
Similarly, when there is little time available to make a deci-
sion, high impulsive individuals respond with greater accura-
cy than low impulsive individuals (Dickman and Meyer
1988). In line with this early evidence, it was recently shown
that trait impulsivity boosts performance in highly rewarding
settings (Cools et al. 2005). Similar conclusions on the advan-
tages of impulsivity can be drawn from other contexts, includ-
ing entrepreneurship (Lerner et al. 2019; Verheul et al. 2015),
and creative literature (Lawrence et al. 2008; White and Shah
2011), and are consistent with the recognised role of context in
the expression of ADHD (Barkley 2002; Williams and Dayan
2005). Thus, environments encompassing novel, interesting,
and fast-paced activities improve ADHD symptoms among
young adults (Lasky et al. 2016).
However, despite growing evidence in humans that im-
pulsivity can confer some adaptive advantages, research in
experimental animals is lacking. To investigate whether
higher levels of impulsivity can be advantageous in certain
contexts, we tested rats on the 5-choice serial reaction time
task (5CSRTT) and presented them with pseudo-randomly
interleaved inter-trial intervals (ITI) of varying durations
from relatively short intervals, of 3 and 5 s in duration, to
longer intervals, of 7 and 9 s in duration. We predicted that
high impulsive (HI) rats, who typically respond prematurely
before the occurrence of any light cue, would perform better
when the task requires them to respond quickly whilst low
impulsive (LI) rats would be impaired. On the contrary, we
expected LI rats to have superior performance when the task
required animals to wait longer for the stimulus to appear.
To further test how performance on rapid trials was affected
by context (i.e. the presentation of interleaved slow and
rapid trials) and the extent to which HI and LI rats adapt
to high-event rate trials, we also evaluated the effects of
short trial presentations, with pseudo-randomly interleaved
3 s and 2 s ITIs. The variable ITI (vITI) paradigm offers a
range of ITIs and can thus allow different behavioural ten-
dencies to emerge. In addition, the unpredictability in the
presentation of each ITI increases attentional load, whilst
controlling for the habituation or timing strategies that the
animals may adopt as the session progresses (Bizarro et al.
2004; Cope et al. 2016). Whilst other studies have examined
performance under vITI versions of the 5CSRTT (Bizarro
et al. 2004; Callahan et al. 2019; Carli et al. 1983; Navarra
et al. 2008; Paterson et al. 2011; Robinson 2012; Sirviö
et al. 1993), none have yet investigated whether HI and LI
rats perform differentially during this experimental manipu-
lation and whether a specific impulsivity phenotype confers
a selective advantage in performance. Blondeau and Dellu-
Hagedorn (2007) tested whether rats segregated on the basis
of impulsivity as well as attentional accuracy show a selec-
tive advantage in long (8 s) ITI as opposed to short (2 s) ITI
trials. Those authors, however, presented trials in isolation as
separate challenges and only measured percentage premature
responses and percentage correct responses as indexes of
performance efficiency. Percentage correct responses, how-
ever, does not adequately test whether a specific phenotype
has an advantage in performance since it obscures informa-
tion on incorrect responses and could thus just indicate a
more or less prominent response bias in a specific ITI, but
not superior performance. In our study, we instead assessed
reinforcers earned and omission responses, as well as pre-
mature responses, to test the hypothesis that HI and LI rats
exhibit different advantages in performance depending on
the ITI. Finally, Blondeau and Dellu-Hagedorn (2007) did
not test the stability of performance of different impulsivity
phenotypes, whilst we tested this on multiple sessions and in
two separate batches of animals, thus strengthening the va-
lidity of our results.
Additionally, we administered pharmacological agents
that are widely used to treat ADHD — d-amphetamine
(AMPH), methylphenidate (MPH) and atomoxetine (ATO)
— to investigate how different medications affect the per-
formance of animals segregated on the basis of their im-
pulsivity phenotype. Importantly, we chose drugs with dif-
ferent though overlapping effects on catecholamine trans-
mission to more precisely dissect the contribution of dis-
tinct neurotransmitter systems in the vITI-5CSRTT para-
digm. On the basis of evidence showing that AMPH and
MPH impair ‘waiting’ impulsivity (Navarra et al. 2008;
Pattij et al. 2007) and decrease response latency (Bizarro
et al. 2004), we predicted that administration of these drugs
would lead to an improvement of performance in short ITI
trials especially. On the contrary, since ATO reduces im-
pulsivity (Blondeau and Dellu-Hagedorn 2007) and slows
responding in some contexts (Callahan et al. 2019), we
predicted that ATO would mostly enhance performance
on long ITI trials. To better dissect the role that noradren-
aline (NA) plays in modulating performance of HI and LI
rats, we also assessed the effects of systemic administration
of atipamezole (ATI), an alpha-2a antagonist, and phenyl-
ephrine (PHEN), an alpha1 agonist. To the best of our
knowledge, ATI and PHEN have not been tested on ani-
mals segregated based on impulsivity; thus, it is unknown
how these drugs would interact with this phenotype. In
addition, PHEN has never been tested on a vITI paradigm
such as the one used in this experiment. On the basis of
evidence showing that ATI increases behavioural activation
(Ma et al. 2005; Sirviö et al. 1994), whilst PHEN has the
opposite effect (Pattij et al. 2012), we predicted that the
former would improve performance during short ITI trials,
whilst the latter would impair performance.
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Methods and materials
Subjects
Sixty outbred male Lister Hooded rats (Charles River,
Margate, UK) weighing 280–300 g at the beginning of the
experiments were used for this study. Animals were acclima-
tised to the animal facility under a 12 h:12 h light cycle (lights
off at 7 AM) for a minimum of 7 days before any procedure
began. When rats reached a body weight of approximately
300 g, they were food-restricted to maintain approximately
90% of their free-feeding weight trajectory (19 g of Purina
rodent chow per animal and day; adjusted for reward pellet
consumption during testing). Water was available ad libitum,
and food was given at the end of each day’s testing. All pro-
cedures conformed to the UK (1986) Animal (Scientific
Procedures ) Ac t (Pro jec t l i cence PA9FBFA9F:
Neurobehavioural mechanisms of mental health, held by Dr.
A. L. Milton) and were approved by the local Ethics
Committee at Cambridge University.
Behavioural apparatus
Twelve five-hole operant chambers (Med Associates,
Georgia, VT) controlled by two computers and Whisker
Control software (Cardinal and Aitken 2010) were used.
Each chamber was enclosed in a ventilated sound-
attenuating box, fitted with five apertures in a curved wall
and a food magazine on the opposite wall of the box that
delivered rodent sugar pellets (TestDiet®, Purina, UK). A
yellow light-emitting diode stimulus was placed at the rear
of each aperture. The food magazine and entire chamber were
illuminated by light emitting diodes. Infrared beams detected
responses in the magazine and apertures.
Five-choice serial reaction time task: training
All rats were trained in the 5CSRTT as described previously
(Bari et al. 2008). Animals were trained to detect a brief visual
cue appearing in one of five apertures of the operant cham-
bers. Each trial is initiated when the rat pokes into the food
magazine, and the visual cue is presented after an ITI of 5 s. A
response was deemed ‘correct’ if the animal poked into the
hole where the light was presented within 5 s of target presen-
tation. A nose-poke response occurring before the appearance
of the visual cue was considered ‘premature’, whilst a re-
sponse occurring in any of the apertures where the light was
not presented was considered ‘incorrect’. A failure to respond
within 5 s of target presentation was recorded as an ‘omission’
of response. Only correct responses were rewarded with a
food pellet (Noyes dustless pellets, Research Diets, UK),
whilst incorrect, premature and omission responses were
punished with a time-out period of 5 s. During a time-out,
the animal was required to wait for the beginning of the next
trial in order to engage again with the task. Nose-pokes in any
of the holes made after a correct or incorrect response, but
prior to reward collection, were deemed ‘perseverative’ but
were not signalled by punishment. Each session lasted a max-
imum of 100 trials or 30 min, whichever limit was reached
first. During the training session, stimulus duration was set at
30 s and was gradually decreased over sessions until animals
reached stable baseline performance (accuracy, >80% correct
choice and <20% errors of omission). In Experiment 1, thirty-
six animals were trained to reach a stable baseline perfor-
mance on the 5CSRTT with a final stimulus duration of
0.7 s and an ITI of 5 s. In Experiment 2, twenty-four animals
were trained to reach a stable baseline performance on the
5CSRTT with a final stimulus duration of 0.6 s and an ITI
of 5 s.
Experiment 1: Effects of impulsivity trait on
behavioural performance at variable ITIs
Variable ITI challenge
Thirty-six rats reached a stable baseline performance and were
subsequently exposed to two vITI sessions. Each vITI session
was followed by at least 1 day of baseline testing where rats
were run according to the baseline parameters specified above.
Each vITI session consisted of a pseudo-random presentation
of trials with 3 s, 5 s, 7 s, and 9 s ITI (mean of 6 s). Each ITI
was presented at least 50 times, and the session ended when
animals had completed 200 trials or after 2 h (whichever event
occurred first). Animals could not predict which ITI was going
to be presented on each trial. Time-out (0.5 s) and stimulus
duration (0.7 s) were kept constant at the same level as their
baseline training. To identify which animals exhibited ex-
treme impulsivity phenotypes, rats underwent an impulsivity
screening procedure. Specifically, premature responses across
the 2 days of vITI challenge were averaged, and the upper (i.e.
the 9 highest-impulsive rats) and lower (i.e. the 9 lowest-
impulsive rats) were selected. Animals falling between these
two extremes were classified as mid-impulsive (MI) rats.
Short vITI challenge: rapid stimulus presentation
A day after their last vITI challenge, rats were presented with a
short vITI session. This consisted of 100 trials of 3 s ITI and
50 trials of 2 s ITI (mean of 2.6 s). The two different ITI trials
were pseudo-randomly interleaved, and the rat could not pre-
dict which ITI trial was going to be presented. The session
ended when rats had completed 150 trials or after 1 h and
30 min (whichever occurred first). More instances of the 3 s
ITI were presented compared to the 2 s ITI, to avoid making
the task too difficult (and risk having floor effects), whilst still
exploring whether rats could be challenged with even quicker
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ITI trials than 3 s and whether trait impulsivity influenced
performance on these two ITIs differently.
Experiment 2: Effects of methylphenidate,
atomoxetine, amphetamine, atipamezole and
phenylephrine on vITI performance
Variable ITI challenge
Twenty-four rats were exposed to three vITI sessions similar
to those of Experiment 1. Each vITI session was followed by
at least 1 day of baseline testing with the baseline parameters
specified above. Each vITI session consisted of a pseudo-
random presentation of trials with 3 s, 5 s, 7 s and 9 s ITI.
Each ITI was presented at least 50 times; the session ended
when animals had completed 200 trials or when 2 h had
passed (whichever occurred first). Animals could not predict
which ITI was going to be presented on each trial. Time-out (5
s) and stimulus duration (0.6 s) were kept constant at the same
level as that of their baseline training. To identify which ani-
mals exhibited extreme impulsivity phenotypes, rats
underwent a screening procedure. Specifically, premature re-
sponses across the 3 days of vITI challenge were averaged,
and the upper (N = 6) and lower (N = 6) quartiles were select-
ed. Animals falling between these two extremes were deemed
MI impulsive rats. Following this challenge, rats were also
tested on a fixed 7 s ITI session to compare behaviour on
the vITI challenge with previous studies on impulsive
responding using a fixed 7 s ITI procedure.
Systemic drug administration
All rats (HI, MI and LI) received control injections of the
vehicle 2 days before the start of the experiment. All drugs
were administered sub-cutaneously (s.c.) 40 min prior to test-
ing. The drug experiments consisted of two separate
randomised within-subject cross-over Latin-square designs,
to control for training and crossover effects. These two
Latin-square designs were separated by at least 3 days of
washout. In Latin-square 1, vehicle, MPH (1 mg/kg and 3
mg/kg) and ATO (0.3 mg/kg and 1mg/kg) were administered.
In Latin-square 2, vehicle, AMPH (0.2 mg/kg), ATI (0.3
mg/kg) and PHEN (1 mg/kg) were administered. All drugs
were dissolved in 0.9% saline and vehicle consisted of just
0.9% saline. Drugs were tested on vITI challenges only (mean
ITI of 6 s).
Data analysis
The main dependent variables were percentages of premature
responses, percentages of omission responses, the number of
reinforcers earned and response latencies to make correct, in-
correct or premature responses. To assess the temporal profile
of responses, we divided the vITI sessions into 5-min bins.
Each bin had to have responses from at least three animals
from each impulsivity group to be included in the analyses.
The 5-min bins satisfying this criteria, across different ses-
sions and cohorts of animals, were from 5 to 55 min (11 bins).
Percentages, number of reinforcers and the number of ac-
tive responses per unit of time were square root transformed.
Latencies were log-transformed. Transformations were ap-
plied to enable comparisons with previous publications
(Hervig et al. 2020; Milstein et al. 2010) and to avoid incur-
ring issues of non-normal data distributions. Statistical tests
were performed with RStudio, version 1.2.1335 (RStudio,
Inc). Data were subjected to Linear Mixed-Effects Model
analysis with the lmer package in R. To validate whether the
data transformations improved model fit, we compared the
AIC values of the models with transformed and non-
transformed data. The model with transformed data yielded
the lowest AIC values for all variables. For analyses of behav-
iour prior to any drugmanipulation, the model contained three
fixed factors (day, ITI and impulsivity) and one factor
(subject) modelled as a random slope to account for individual
differences between rats across testing days. When significant
three-way interactions were found, further analysis was per-
formed by conducting separate multilevel models on ‘day’.
For analyses of drug interventions, the model contained three
fixed factors (ITI, impulsivity and drug) and one factor (sub-
ject). When significant three-way interactions were found,
further analysis was performed by conducting separate multi-
level models on ‘impulsivity’. For all analyses, significance
was considered at α = 0.05. When significant interactions
were found, further analysis was performed by conducting
post hoc Tukey’s corrected pairwise comparisons. For drug
manipulations, post-hoc testing was used to determine differ-
ences with vehicle treatment only.
Results
Baseline performance prior to the vITI challenge was analysed
and is reported in detail in the supplementary materials.
Briefly, on baseline, HI rats exhibited elevated premature re-
sponses compared with the other two groups.
Experiment 1: Effects of impulsivity trait on
behavioural performance at variable ITIs
For reinforcers earned, there was a significant Day × ITI ×
Group interaction (F(6,231) = 2.89, p = 0.010). Since the
three-way interaction was significant, separate multilevel
models were used to ascertain the Group dependency of the
ITI effects in each Day separately. Impulsivity phenotype de-
termined the efficacy of performance in terms of earned rein-
forcers at different ITI values for the second day of testing
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(Group × ITI interaction, F(6,99) = 21.91, p < 0.001). This is
shown in Fig. 1A where HI rats obtained more reinforcers
than LI rats (t = 6.30, p < 0.001) and MI (t = 4.51, p <
0.001) on the short 3 s ITI trials, with MI rats also earning
more reinforcers than LI on the short 3 s ITI trials (t = 2.77, p =
0.018). HI also earned more reinforcers than LI on the 5 s ITI
trials (t = 2.81, p = 0.002) but earned fewer reinforcers than LI
(t = −3.65, p = 0.012; t = −4.69, p < 0.001) and MI (t = −2.87,
p = 0.009; t = −2.55, p < 0.001) on the long 7 s and 9 s ITI
trials, respectively. A similar effect was evident on day 1 of
testing as shown by Figure S1a in the supplementary mate-
rials. In summary, HI rats earned more reinforcers at shorter
ITI trials, whilst LI rats earned more reinforcers at longer ITI
trials.
Both impulsivity phenotype and ITI influenced the inci-
dence of omission responses (Group × ITI, F(6,231) = 2.76,
p = 0.013). Figure 1B shows data for the second day of testing.
LI rats made proportionally more omission responses than HI
rats (t = −5.06, p < 0.001) and MI (t = −3.82, p <0.001) on the
short 3 s ITI. LI rats also made more percentages of omission
errors than HI rats on the 5 s ITI trials (t = −2.80, p = 0.018). In
summary, LI rats were more prone than HI and MI at making
omission errors, and these occurred on short ITI trials.
For percentages of premature responses, there was a signif-
icant Day × ITI × Group interaction (F(6,231) = 3.26, p =
0.004). Since the three-way interaction was significant, sepa-
rate multilevel models were used to ascertain the Group de-
pendency of the ITI effects in each Day separately.
Impulsivity phenotype and ITI influenced the frequency of
premature responses in the second day of testing (Group ×
ITI interaction, F(6,99) = 12.92, p < 0.001). Figure 1C shows
that HI rats made proportionally more premature response
than LI and MI rats during 5 s ITIs (t = 3.34, p = .003; t =
3.77, p < 0.001, respectively), 7 s ITIs (t = 9.16, p < 0.001; t =
7.24, p < 0.001, respectively) and 9 s ITIs (t = 7.96, p < .001; t
= 5.86, p < 0.001, respectively). MI rats also made more
percentages of premature response than LI rats on the 7 s ITI
(t = 3.34, p = 0.003) and the 9 s ITI (t = 3.33, p = 0.004). A
similar pattern was evident on day 1 as shown by Figure S1b
in the supplementary materials. In summary, HI rats and to an
extent MI rats made proportionally more premature responses
than LI rats, and these occurred during the long ITI trials.
We then combined premature, correct and incorrect re-
sponses and divided the session into 5-min bins to examine
whether HI, MI and LI rats differ in overall rate of responding.
There was an effect of impulsivity phenotype on number of
active responses per unit of time (F(2,33) = 6.32, p = 0.005).
Specifically, HI rats were significantly more active than LI
rats (t = 3.54, p = 0.003). For more details on this, see
Figure S2 in the supplementary materials.
We next assessed the relationships between the various
behavioural variables. During the first (r = −0.46, p = 0.005)
and second (r = −0.37, p = 0.028) day of testing, there was an
overall significant negative relationship between making an
omission on the 3 s ITI and making a premature response on
the 9 s ITI. There was also a strong positive correlation be-
tween making a correct response on the 3 s ITI and making a
premature response on the 9 s ITI both on day 1 (r = 0.64, p <
0.001) and on day 2 (r = 0.64, p < 0.001). These correlations
are in line with behavioural data analysed by impulsivity phe-
notype, showing that animals that respond prematurely during
long ITI trials are also more likely to respond correctly on
short ITI trials. Conversely, animals that do not engage with
rapid, short ITI trials, and thus make many omissions on these
trials, are more likely to respond correctly when waiting is
rewarded. Finally, impulsivity groups and ITI types influ-
enced latency to perform correct and premature responses.
For more details on this, see Table 1.
Short vITI challenge
We next tested rats with short vITI trials of 2 and 3 s (mean of
the vITI session: 2.6 s). Figure 2A shows that the impulsivity
groups differed with regard to reinforcers earned (F(2,33) =
3.65, p = 0.037) with HI rats earning significantly more rein-
forcers than LI rats (t = 2.53, p = 0.041). As shown in Fig. 2B,
omissions varied as a function of ITI (F(1,33) = 206.33, p <
0.001) and impulsivity group (F(2,33) = 7.53, p = 0.002).
Fig. 1 Trait impulsivity modulates performance on a vITI paradigm on 5CSRTT. Group differences for Day 2 in (A) reinforcers earned, (B) percentages
of omission errors and (C) percentages of premature responses. *HI vs LI p < 0.05; #HI vs MI p < 0.05; §MI vs LI p < 0.05
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Percentages of omission errors were higher during 2 s ITI
trials than 3 s ITI trials (t = 14.36, p < .001), and HI rats made
significantly less of these errors than LI (t = −3.77, p = 0.002)
and MI (t = −2.94, p = 0.023) rats. These findings show that
HI rats show a superior performance compared with LI rats
during fast-paced trials.
Latencies to make a correct response varied significantly
across different ITIs (F(1,33) = 69.29, p < 0.001) and impul-
sivity groups (F(2,33) = 4.17, p = 0.024). Latencies to make
an incorrect response also varied depending on ITI (F(1,33) =
6.52, p = 0.015). For details on this, see Table S1 in the
supplementary materials.
Experiment 2: Effects of methylphenidate,
atomoxetine, amphetamine, atipamezole and
phenylephrine on vITI performance
Prior to the drug administration studies, rats were trained to a
stable baseline level and were tested on three vITI sessions.
On baseline, HI rats exhibited elevated premature responses
and lower accuracy compared with LI rats (for more details,
see the supplementary materials).
Results from the vITI challenges replicated Experiment 1
and are shown in the supplementary section (see Table S2 and
Figures S3–S5). Briefly, HI rats earned more rewards and
made fewer omissions when the task required rapid informa-
tion in short ITI trials. When the ITI was increased to longer
durations, HI rats showed more premature responses than LI
rats. LI rats exhibited the opposite behavioural profile with
more rewards during long ITI trials and impaired performance
during the short ITI trials with increased omissions. Finally,
rats were also tested on a fixed 7 s ITI session, to allow com-
parisons with previous publications. Briefly, HI rats
categorised using the variable ITI procedure exhibited signif-
icantly increased levels of premature responding compared
with LI rats and MI rats during a fixed 7 s ITI session (for
more details see, the supplementary materials).
Figure 3A,B shows that the effects of ATO and MPH on
behaviour depended on the ITI (Drug × ITI interaction,
F(12,380) = 28.52, p < 0.001). As shown in Fig. 3A, during
Table 1 Experiment 1, vITI challenge. Latencies for correct, incorrect and premature responses.
Correct responses Incorrect responses Premature responses









































*HI vs LI p < 0.05
°HI vs MI p < 0.05
Fig. 2 Trait impulsivity modulates performance on a short vITI paradigm on 5CSRTT. Group differences in (A) reinforcers earned and (B) percentages
of omission errors. *HI vs LI p < 0.05; #HI vs MI p < 0.05
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short 3 s and 5 s ITI trials, ATO (1 mg/kg) significantly de-
creased the number of reinforcers earned compared with ve-
hicle (t = 7.23, p < .001; t = 6.39, p < .001 respectively for 3 s
and 5 s ITI trials). ATO (1 mg/kg) also reduced the number of
reinforcers earned during the long 7 s ITIs compared with the
vehicle group (t = 3.89, p < 0.001).
In contrast, during short 3 s ITI trials, rats earned more
reinforcers following the administration of MPH at both low
(1 mg/kg, t = 6.91, p < 0.001) and high (3 mg/kg, t = 7.92, p <
0.001) doses compared with the vehicle group. The beneficial
effect of 1 mg/kg MPH extended to the 5 s ITI compared to
vehicle (t = 3.20, p = 0.005). However, similar to ATO, during
long ITI trials with high-dose MPH (3 mg/kg), performance
deteriorated both on the 7 s and 9 s ITI trials (t = 4.10, p <
0.001; t = 4.41, p < 0.001 respectively). Low-dose MPH (1
mg/kg) impaired performance during the 9 s ITI trials (t =
3.49, p = 0.002).
ATO affected performance differently depending on the
impulsivity phenotype (Drug × Group interaction, F(8,380)
= 2.31, p = 0.020). Specifically, high-dose ATO (1 mg/kg)
worsened performance mostly of MI (t = 5.72, p < 0.001) and
LI rats (t = 7.66, p < 0.001) and only produced a trend level
decrement in performance for HI rats (t = 2.37, p = 0.063, see
Fig. 6A).
ATO and MPH affected the percentages of omission errors
differently depending on the ITI (Drug × ITI, F(12,380) =
5.38, p < 0.001). Figure 4A shows that treatment with high-
dose ATO (1 mg/kg) increased the percentages of omission
responses compared to vehicle on all ITIs (3 s ITI: t = 6.82, p <
0.001; 5 s ITI: t = 8.43, p < 0.001; 7 s ITI: t = 7.17, p < 0.001;
9 s ITI: t = 5.78, p < 0.001).
In contrast, Fig. 4B shows that treatment with both high (3
mg/kg) and low-dose (1mg/kg)MPH reduced the percentages
of omission responses on short 3 s ITI trials (t = −7.16, p <
0.001; t = −6.82, p < 0.001 for the high and low doses
respectively).
Both ATO and MPH modulated performance differently
depending on the impulsivity phenotype (Group × Drug,
F(8,380) = 2.20, p = 0.026). Specifically, low-dose ATO
(0.3 mg/kg) increased the percentage of omission responses
solely for MI rats (t = 4.74, p < 0.001) whilst high-dose (3
mg/kg) and low-dose (1 mg/kg) MPH decreased the
Fig. 3 (A) Effects of ATO on reinforcers earned; *low-dose vs vehicle p < 0.05; #high-dose vs vehicle p < 0.05. (B) Effects of MPH on reinforcers
earned; *low-dose vs vehicle p < 0.05; #high-dose vs vehicle p < 0.05
Fig. 4 (A) Effects of ATO on percentages of omission errors; *low-dose vs vehicle p < 0.05; #high-dose vs vehicle p < 0.05. (B) Effects of MPH on
percentages of omission errors; *low-dose vs vehicle p < 0.05; #high-dose vs vehicle p < 0.05
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percentage of omission responses both for HI (t = 4.42, p =
0.001; t = 4.05, p < 0.001; respectively) and LI rats (t = 3.45, p
= 0.004; t = 3.86, p = 0.013; respectively; see Fig. 6C,D).
ATO and MPH affected the percentages of premature re-
sponse differently depending on the ITI (Drug × ITI,
F(12,380) = 15.02, p < 0.001). Figure 5A shows that admin-
istration of ATO both low-dose (0.3 mg/kg) and high-dose (1
mg/kg) decreased the percentage of premature responses on
trials with 7 s (t = 3.75, p < 0.01; t = 7.62, p < 0.01 for the low
and high doses respectively) and 9 s ITIs (t = 3.74, p < 0.01; t
= 9.44, p < 0.01 for the low and high doses respectively).
High-dose ATO (1 mg/kg) also decreased the percentage of
premature responses on the 5 s ITI trials (t = 3.40, p = 0.003).
On the contrary, Fig. 5B shows that administration of both
low-dose (1 mg/kg) and high-dose (3 mg/kg) MPH increased
the percentage of premature responses on the 5 s, 7 s and 9 s
ITI trials (low-dose: 5 s ITI t = 3.73, p < 0.001; 7 s ITI t = 6.96,
p < 0.001; 9 s ITI t = 4.86, p < 0.001; high-dose: 5 s ITI t =
9.07, p < 0.001; 7 s ITI t = 9.99, p < 0.001; 9 s ITI t = 5.86, p <
0.001). High-dose MPH (3 mg/kg) also increased the percent-
age of premature responses in the 3 s ITI trials (t = 3.71, p <
0.001).
ATOmodulated performance differently depending on im-
pulsivity phenotype (Group × Drug, F(8,380) = 2.82, p =
0.004). Specifically, low-dose ATO (0.3 mg/kg) decreased
the percentage of premature responses compared with vehicle
in MI (t = 5.38, p < 0.001) and LI (t = 2.98, p = 0.012) but not
in HI rats (t = 0.83, p = 0.780; see Fig. 6B). Latencies on
correct, incorrect and premature responses following admin-
istration of ATO and MPH are shown in Tables S3–S5 of the
supplementary materials.
The above findings show that MPH and ATO have essen-
tially opposite effects on performance. Whereas MPH led to a
general activation of behaviour, increasing premature re-
sponses, decreasing omissions and facilitating responding on
short ITI trials, the administration of ATO produced a general
inhibition of behaviour with reduced premature responses
during long ITI trials and increasing omissions, especially
during short ITI trials. Finally, the action of ATO was depen-
dent on trait impulsivity and affected MI and LI rats more so
than HI rats.
Effects of amphetamine, atipamezole and phenylephrine
Figure 7A shows that AMPH, PHEN and ATI affected per-
formance on long and short ITI trials differently depending on
the ITI (Drug × ITI, F(9,285) = 17.19, p < 0.001).
Specifically, in the short 3 s ITI trials, animals earned more
pellets after administration of AMPH compared with vehicle
(t = 5.62, p < 0.001), but less pellets after administration of
PHEN (t = −3.42, p = 0.002). There was also a trend for
animals to earn more pellets on 3 s ITI trials following the
administration of ATI compared to vehicle (t = 2.25, p =
0.068). During long 7 s and 9 s ITI trials, animals earned
significantly fewer pellets following administration of
AMPH compared to vehicle (t = −4.28, p < 0.001; t =
−4.69, p < 0.001 respectively). During 7 s ITI trials, there
was a trend for animals to earn less pellets following admin-
istration of ATI compared to vehicle (t = −2.27, p = 0.064).
This effect was significant in the 9 s ITI trials (t = −3.20, p =
0.004).
Omission responses were affected differently by AMPH,
ATI and PHEN depending on the ITI (Drug × ITI, F(9,285) =
5.88, p < 0.001). Figure 7B shows that treatment with ATI (t =
2.30, p = 0.05) and AMPH (t = 6.10, p < .001) reduced the
percentage of omission responses on the short 3 s ITI trials;
however, PHEN increased the percentage of omission re-
sponses on the 3 s and 5 s ITI trials (t = 4.49, p < 0.001, t =
3.69, p = 0.001 respectively). In addition, AMPH reduced
omission responses on the 7 s ITI trials (t = 2.41, p = 0.046).
Premature responses were affected differently by AMPH,
ATI and PHEN depending on the ITI (Drug × ITI, F(9,285) =
4.77, p < 0.001). Figure 7C shows administration of AMPH
increased the percentage of premature responses in trials with
Fig. 5 (A) Effects of ATO on percentages of premature responses; *low-dose vs vehicle p < 0.05; #high-dose vs vehicle p < 0.05. (B) Effects ofMPH on
percentages of premature responses; *low-dose vs vehicle p < 0.05; #high-dose vs vehicle p < 0.05
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5 s (t = 6.07, p < .001), 7 s (t = 6.76, p < .001), 9 s (t = 3.15, p <
.001) ITIs, whereas ATI only increased premature responses
during 5 s (t = 2.83, p = 0.014) and 7 s (t = 3.08, p = 0.007)
ITIs. Latencies on correct, incorrect and premature responses
following administration of ATI, AMPH and PHEN are
shown in Table S6 of the supplementary materials.
The effects of AMPH, ATI and PHEN were determined by
ITI. Administration of AMPH and ATI led to behavioural
disinhibition: increasing premature responses, decreasing
omissions and facilitating responding on fast-paced, short
ITI trials. Administration of PHEN, instead, led to a general
inhibition of behaviour: reducing premature responses and
increasing omissions, especially during short ITI trials.
Discussion
The findings show that high and low levels of impulsivity can
be both detrimental and advantageous to task performance,
depending on the precise contingencies of the test environ-
ment. Specifically, HI rats performed best with short ITIs
and fast stimulus presentations whilst LI rats were superior
Fig. 6 (A–D) Interaction between drug and trait impulsivity. Effects of ATO and MPH on reinforcers earned, percentages of premature responses and
percentages of omissions. *p < 0.05
Fig. 7 Effects of AMPH, ATI and PHEN on (A) reinforcers earned, (B) percentages of omission responses and (C) percentages of premature responses
*AMPH vs vehicle p < 0.05; #ATI vs vehicle p < 0.05; §PHEN vs vehicle p < 0.05
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during the long ITI trials of the vITI-5CSRTT. Moreover, the
effects of drugs used to treat ADHD also depended on the
context of the test situation as well as baseline levels of im-
pulsivity. Specifically, drugs that increase the levels of cate-
cholamines both cortically and subcortically, such as MPH
and AMPH, conferred an advantage in the short ITI trials of
the 5CSRTT and mimicked the behavioural profile of HI rats.
In contrast, the selective NA reuptake blocker ATO (Swanson
et al. 2006) which also increases DA in the prefrontal cortex
but has no effect on DA levels in the striatum (Carboni et al.
2006) decreased impulsivity, slowed response latencies and
improved performance in long ITI trials, mimicking the be-
haviour of LI rats. Importantly, we noticed that the effect of
ATO was partly dependent on trait impulsivity and exerted
greater influence on behaviour inMI and LI rats. The contrast-
ing effects of MPH and ATO implicate DA and NA in differ-
ent aspects of sustained attentional performance.
In two separate experiments, over multiple sessions, HI
animals earned more reinforcers and made fewer omission
responses than LI and MI animals in the short, 3 s and 5 s
ITI trials. In addition, HI were on average faster at making a
correct response, regardless of ITI. This adaptive response
was not the result of a strategy chosen based on the available
contingencies. Indeed, when animals were challenged with a
session that presented only short ITIs, LI (and to a lesser
extent MI) rats were not able to adapt to the short latencies
and performed significantly worse than HI rats. Conversely,
when the task required animals to wait for an extended period
before responding, the behavioural phenotype typical of HI
rats emerged, with increased premature responses during the
long 7 s and 9 s ITIs. This suggests that there is some adaptive
value to the impulsivity phenotype. The advantage that this
trait confers is revealed under high-event rate conditions,
where rapid information processing, including visual attention
and action, is required. The significance of these findings can
be seen from work in humans showing that task pace and
frequency of reinforcers improve performance of impulsive
subjects (Cools et al. 2005) and ADHD juveniles (Delisle
and Braun 2011; McInerney and Kerns 2003; Slusarek et al.
2001; Strand et al. 2012), normalising behaviour or even im-
proving behaviour compared with matched healthy controls.
Some have attributed this phenomenon to an intolerance of
delayed rewards and increased susceptibility to boredom
(Barkley 2001; Wiersema et al. 2006), suggesting that unin-
teresting or non-stimulating tasks foster the development of
ADHD symptoms, whilst fast-paced and motivating contexts
reduce their occurrence. This is particularly relevant for the
present study with a superior performance of HI rats during a
high-event rate challenge.
LI rats tended to stop responding on the fast trials but con-
tinued towork on the 7 s and 9 s ITI trials. Indeed, HI rats were
on average faster and more active than LI rats throughout the
session. Short latencies and greater activity-per-unit-of-time
have been postulated to require greater energy and thus be
more costly (Niv et al. 2005, 2007; Opris et al. 2011;
Staddon 2001). Niv et al. (2005, 2007) explored this idea
computationally, suggesting that the expectation of future re-
ward determines the rapidity or vigour with which the operant
is performed by functioning as an opportunity cost, that is by
determining whether the cost of responding fast and/or fre-
quently is worth the outcome. Building on this idea, both rats
(Opris et al. 2011) and humans (Shadmehr 2010) respond
faster and with greater vigour when the opportunity to gain a
reward is high, whereas they are slower and less active when
the expected reward from any given action is low. This cor-
roborates the hypothesis that movement kinematics are dictat-
ed by the value attributed to a stimulus and by the rate at which
this value is discounted in time (Shadmehr 2010). This would
suggest that steeper than normal temporal discounting of re-
ward would be accompanied by faster and more vigorous
movements. Consistent with this idea, subjects showing im-
paired waiting impulsivity (Choi et al. 2014; Wallace and
Newman 1990) or proneness to boredom (Berret et al. 2018)
make faster and more vigorous movements.
This is in line with our data, showing that high impulsive
animals, who are steeper discounters (Robinson et al. 2009),
have faster responding and demonstrate superior performance
when such behaviour is advantageous. According to the nor-
mative account described by Niv et al. (2007), the more vig-
orous responding of HI rats would indicate enhanced subjec-
tive utility of food reward for this endophenotype.
Interestingly, both in rodents and in humans, impulsive action
has been associated with indices of greater sensitivity to
reward-predicting cues, such as risky decision-making
(Barrus et al. 2015; Gabriel et al. 2019; Ioannidis et al.
2019), substance abuse (Belin et al. 2008; Dalley et al. 2007;
Diergaarde et al. 2008, 2009; Voon 2014) and increased
responsivity for sucrose (Diergaarde et al. 2009). Recent data
in humans supports the idea that motor impulsivity is associ-
ated with enhanced value attribution to reinforcers
(Mechelmans et al. 2017); however, we did not test this di-
rectly in this study.
Results from the pharmacological interventions show that
the effects that drugs have on behavioural performance can be
both context and trait dependent. Specifically, drugs that in-
crease the release of dopamine and noradrenaline both corti-
cally and subcortically, such as MPH and AMPH (Bymaster
et al. 2002; Kuczenski and Segal 2001), reduced response
latencies and improved performance on fast-paced trials. In
long ITI trials, instead, they increased premature responses
and deteriorated performance, mimicking, as a whole, the be-
haviour of HI rats. Behavioural results obtained with these
drugs agree with previous research on impulsive action,
whereby increasing extracellular DA levels, in particular in
the striatum (Economidou et al. 2012), leads to enhanced be-
havioural activation and more premature responses
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(Baarendse and Vanderschuren 2012; Milstein et al. 2010;
Murphy et al. 2008; Navarra et al. 2008; Pattij et al. 2007;
Sun et al. 2012). Navarra et al. (2008) had also observed an
improvement of performance on the 5CSRTT with MPH on
some short ITI trials; we confirm these findings and extend
this effect to low-dose AMPH. These results add to a growing
body of literature on the pro-cognitive effects of
psychostimulants in animals (Paine et al. 2007; Tomlinson
et al. 2014; Turner et al. 2016) and in humans (Pietrzak
et al. 2006; Wardle et al. 2011). These results are also in line
with computational (Niv et al. 2005, 2007) and experimental
evidence (Hamid et al. 2016; Klaus et al. 2019; Mohebi et al.
2019; Wassum et al. 2012) that increased DA transmission in
the striatum lowers the threshold for action initiation and in-
vigorates operant responding by a process of activation
(Robbins and Everitt 2007). Importantly, these findings also
suggest that the advantage conferred by impulsivity in highly
stimulating contexts may be due to increased levels of dopa-
mine in the striatum. This is in line with evidence suggesting
that HI rats present increased synaptic DA levels in the shell
sub-region of the ventral striatum due to reduced expression of
the dopamine transporter and decreased DA D2/D3 receptor
availability in this region (Dalley and Robbins 2017; Jupp
et al. 2013).
Contrary to MPH, systemic administration of ATO, which
increases extracellular NA levels and does not affect DA re-
lease in the striatum but increases it in the PFC (Carboni et al.
2006; Swanson et al. 2006), improved performance on long
ITI trials, increased omissions on short ITI trials and slowed
responding in general, mimicking the behaviour of LI rats.
These results are in line with previous research on 5CSRTT
showing that ATO reduces premature responses in this task
(Blondeau and Dellu-Hagedorn 2007; Economidou et al.
2012; Fernando et al. 2012; Navarra et al. 2008; Robinson
et al. 2008). Contrary to previous evidence (Navarra et al.
2008 5 s ITI 1.0mg/kg; Callahan et al. 2019 2.5 s ITI
3.0mg/kg), however, we did not observe an increase in the
probability to make a correct response in short ITI trials fol-
lowing administration of ATO, and instead we saw a decre-
ment in performance, consistent with a role of ATO in reduc-
ing behavioural activation or even producing mild sedative
effects. Importantly, MI and LI rats were more sensitive to
the deactivating effects of ATO than HI rats; thus, trait-
related factors can determine the behavioural effects of
ATO. Studies using tasks other than the 5CSRTT have also
observed reduced behavioural responding following the ad-
ministration of ATO, such as an increase in omissions on a
cognitive-effort task (Hosking et al. 2015) and a decrease in
breakpoint in a progressive ratio choice task (Yohn et al.
2016). The specific mechanisms of how ATO strengthens
behavioural inhibition are not well understood. In the context
of 5CSRTT, it is possible that ATO reduces premature re-
sponses by increasing NA transmission in the nucleus
accumbens shell (Benn and Robinson 2017; Economidou
et al. 2012). Others have found that administration of ATO
reduces DA release in the nucleus accumbens core, with a
concomitant behavioural effect of decreased willingness to
exert effort in a progressive ratio task (Yohn et al. 2016).
The authors then speculated that ATO may be acting via
alpha-2 adrenergic receptors on dopamine neurons of the ven-
tral tegmental area (VTA) to reduce accumbal DA release
(Guiard et al. 2008; Yohn et al. 2016).
Blockade of the alpha-2a adrenoceptors with ATI yielded
results similar to those of psychostimulants, with a decrease of
omissions in short ITI trials and an increase in premature re-
sponses in long ITI trials. In contrast, the alpha1 adrenoceptor
agonist PHEN resulted in a behavioural profile similar to that
of ATO, reducing correct responses and increasing the prob-
ability of omissions in short ITI trials. These results are in line
with previous research in 5CSRTT (Koskinen et al. 2003;
Pattij et al. 2012; Sirviö et al. 1993) showing that PHEN leads
to an overall inhibition of responding whilst administration of
ATI results in an increase in behavioural activation. Given that
administration of ATI yielded results markedly different from
those of ATO, it is unlikely that ATI is acting on pre-synaptic
alpha-2a autoreceptors on NA fibres to activate NA transmis-
sion (Berridge and Waterhouse 2003). Instead, ATI may be
acting on post-synaptic alpha-2a adrenoceptors subcortically
to increase DA release, either via its action on alpha-2-
autoreceptors on VTA DA cells (Guiard et al. 2008), or by
inhibiting DA decline in the striatum (Yavich et al. 2003).
Alternatively, ATI may act on post-synaptic alpha-2a
adrenoceptors receptors located in the prefrontal cortex.
Studies in non-human primates have shown that blockade of
these receptors with infusions of yohimbine, an alpha-2a an-
tagonist, in the dorsolateral prefrontal cortex, increases impul-
sivity (Ma et al. 2003) and induces locomotor hyperactivity
(Ma et al. 2005).
NA has lower affinity for alpha-1 adrenoceptors compared
to alpha-2 adrenoceptors (Mohell et al. 1983; O’Rourke et al.
1994), and thus alpha-1 adrenoceptors in the prefrontal cortex
are thought to be preferentially engaged during high levels of
stress, when levels of NA release are highest (Ramos and
Arnsten 2007). There is evidence that activation of alpha-1
adrenoceptors in prefrontal cortex impairs working memory
performance both in rodents (Arnsten et al. 1999; Birnbaum
et al. 2004) and monkeys (Arnsten and Jentsch 1997;
Birnbaum et al. 2004; Mao et al. 1999). On the basis of this,
it is possible that the slowing of behavioural activation that we
observe with PHEN could be due to a neocortical action of
this drug.
In conclusion, our findings demonstrate that trait impulsiv-
ity can be advantageous in certain contexts, specifically when
rapid responding and attentional focusing is required. From
human studies on ADHD, it is apparent that stimulating envi-
ronments can help remediate decrements in performance in
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this patient population; however, we have demonstrated, for
the first time to our knowledge, that this is also true in animal
models of impulsivity. Importantly, we have also explored the
role that catecholamines play in the performance of high-event
rate tasks, and we suggest that drugs that elevate subcortical,
as well as cortical, DA levels improve performance on fast-
paced trials, whilst drugs that act mainly to block the reuptake
of NA slow responding in such situations. These results have
important implications for our understanding of impulsivity,
the context within which it manifests and the pharmacological
agents that are used to treat ADHD.
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